Elpis Biopharmaceuticals is a company developing biological and cellular therapeutics for difficult-to-treat cancers. It offers mADs platform to discover fully human therapeutic antibodies and mSCAFold platform to develop mechanism-driven protein therapeutics. Elpis Biopharmaceuticals' pipeline is composed of immuno-modulators, dual targeting tandem CAR-Ts, and bispecific antibodies.